Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. (CODEGY65)

August 7, 2018 updated by: Institut de Cancérologie de Lorraine

Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. Qualitative Approach

Systematic screening for cervical cancer stops in France at 65 years old. The incidence of certain types of gynecological neoplasia increases with age (endometrium, vulva). Diagnosis delay of 8 months has been described for uterine cancer and longer delays for vulvar cancer.

The aim of our study is to understand help-seeking behavior and its delay for this type of cancer among patients older than 65.

Study Overview

Detailed Description

Our study assess the reasons for which the patient took time to go to the doctor despite of their symptoms. We use a qualitative methodology. Our study categorizes lived experiences, recorded in semistructured interview transcripts. We use psychodynamic and semiopragmatic analyses of the discourse to obtain hypotheses about possible reasons of the delay in the help-seeking process."

Study Type

Observational

Enrollment (Actual)

12

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vandœuvre-lès-Nancy, France
        • Institut de Cancérologie de Lorraine (ICL)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women of 65 years or more treated or followed at Lorraine Institute of Oncology Diagnosed after 65 years or later of a low gynecological cancer

Description

Inclusion Criteria:

  • Women of 65 years or more treated or followed at Lorraine Institute of Oncology
  • Diagnosed after 65 years or later of a low gynecological cancer
  • Without diagnosis of dementia
  • Retained ability to express by herself without assistance
  • Affiliated to public health system
  • Informed and having expressed her non-opposition

Exclusion Criteria:

  • Women under 65 or diagnosed before being 65 of a low gynecological cancer
  • Diagnosed of dementia
  • No longer to express herself
  • Patient deprived of freedom

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience of help-seeking period for low gynecological cancers.
Time Frame: 1 day
Qualitative interview performed at one occasion where the patient describes the experience of the help seeking period she has passed through.
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motivators and barriers to help-seeking for low gynecological cancers.
Time Frame: 1 day
qualitative methodology using verbal data analysis of semi-structured interview.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: MARCHAL FREDERIC, MD, Institut de Cancerologie de Lorraine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2017

Primary Completion (Actual)

March 12, 2018

Study Completion (Actual)

July 27, 2018

Study Registration Dates

First Submitted

October 19, 2017

First Submitted That Met QC Criteria

November 7, 2017

First Posted (Actual)

November 8, 2017

Study Record Updates

Last Update Posted (Actual)

August 8, 2018

Last Update Submitted That Met QC Criteria

August 7, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gynecologic Cancer

Clinical Trials on Semi-structured face to face interviews.

Subscribe